CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

47 hedge funds and large institutions have $80.2M invested in Carisma Therapeutics in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.2% less ownership

Funds ownership: 2.62%2.42% (-0.2%)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

Holders
47
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.52M
Puts
$844K
Net Calls
Net Calls Change

Top Buyers

1 +$2.53M
2 +$1.78M
3 +$1.67M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$978K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$388K

Top Sellers

1 -$5.12M
2 -$3.76M
3 -$1.8M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.53M
5
AWS
AJ Wealth Strategies
New York
-$400K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$45K
27
$43K
28
$39K
29
$39K
30
$38K
31
$30K
32
$30K
33
$29K
34
$27K
35
$12K
36
$10K
37
$10K
38
$9K
39
$9K
40
$8K
41
$4K
42
$2.15K
43
$1K
44
$1K
45
$1K
46
$1K
47
48
49
50